UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY)

Q: What does CUSIP 90466Y103 represent in this 13F holders report?

CUSIP 90466Y103 is the security identifier for UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

Q: How many institutions held UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share in Q2 2023?

15 institutional investors reported UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share for Q2 2023. Use the holders table for investor-level position and value details.

CUSIP: 90466Y103

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 18,578,488
Total 13F shares: 1,074,486
Share change: -611,957
Total reported value: $1,375,341
Price per share: $1.28
Number of holders: 15
Value change: -$1,380,929
Number of buys: 7
Number of sells: 5

Quarterly Holders Quick Answers

What is CUSIP 90466Y103?
CUSIP 90466Y103 identifies UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 90466Y103:

Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023

Top shareholders of UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	3.9%	717,349	$1,506,433	—	31 Mar 2023	13F
Nantahala Capital Management, LLC	13F	Company	3.5%	647,416	$1,359,574	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	0.62%	115,057	$241,620	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.52%	95,898	$201,385	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	0.19%	35,036	$73,576	—	31 Mar 2023	13F
CAPTRUST FINANCIAL ADVISORS	13F	Company	0.1%	18,800	$39,480	—	31 Mar 2023	13F
TANDEM CAPITAL MANAGEMENT CORP /ADV	13F	Company	0.08%	15,500	$32,550	—	31 Mar 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.08%	14,600	$30,660	—	31 Mar 2023	13F
Oxbow Advisors, LLC	13F	Company	0.06%	11,861	$24,908	—	31 Mar 2023	13F
Squarepoint Ops LLC	13F	Company	0.06%	11,459	$24,064	—	31 Mar 2023	13F
Tower Research Capital LLC (TRC)	13F	Company	0.02%	3,419	$7,000	—	31 Mar 2023	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	47	$99	—	31 Mar 2023	13F
OSAIC HOLDINGS, INC.	13F	Company	0%	1	$2	—	31 Mar 2023	13F
Brigitte Schiller	3/4/5	Director	— class O/S missing	41,738	—	—	15 Jul 2022	3/4/5

Institutional Holders of UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) as of Q2 2023

As of 30 Jun 2023, UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,074,486 shares. The largest 10 holders included Nantahala Capital Management, LLC, VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Ground Swell Capital, LLC, CAPTRUST FINANCIAL ADVISORS, TANDEM CAPITAL MANAGEMENT CORP /ADV, TWO SIGMA ADVISERS, LP, and Centiva Capital, LP. This page lists 15 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Q2 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.